MONITOR-OA: Using Wearable Activity Trackers to Improve Physical Activity in Knee Osteoarthritis

NCT02315664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2019-10-28

Study results available
· View outcomes & findings →

Summary

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, a 2013 systematic review found only 13% met the activity recommendation of 150 minutes or more per week. The primary goal of this randomized controlled trail is to assess the efficacy of a physical activity counseling model, involving a group education session, the use of Fitbit Flex (a wireless physical activity tracking device), and online/telephone coaching by a physiotherapist (PT), to improve physical activity and reduce sedentary time in patients with knee OA. Engaging in regular physical activity can have the additional benefit of improving cognitive functioning.

Conditions

Interventions

BEHAVIORAL

Education session, Fitbit Flex, and remote coaching by a PT

Participants will receive a brief education session, use of a commercially available physical activity tracker called Fitbit Flex, and remote counseling by a PT. Intervention will be received immediately.

BEHAVIORAL

Same intervention with a 2 month delay

The Delayed Intervention Group will receive the same intervention as the Immediate Intervention Group, but with a 2 month delay.

Sponsors & Collaborators

  • Simon Fraser University

    collaborator OTHER
  • Arthritis Research Centre of Canada

    collaborator OTHER
  • Vancouver General Hospital

    collaborator OTHER
  • University of British Columbia

    lead OTHER

Principal Investigators

  • Linda Li, PhD · Arthritis Research Canada

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-02
Primary Completion
2017-05-17
Completion
2017-05-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02315664 on ClinicalTrials.gov